PHARMACOEPIDEMIOLOGICAL ANALYSIS OF THE PERFORMED CONSERVATIVE TREATMENT IN PATIENTS WITH CHOLELITHIASIS OF THE GERONTOLOGICAL GROUP OF NAMANGAN

According to the WHO, in the modern treatment and diagnostic process of cholelithiasis (CSD) it is important, especially in individuals of the gerontological group (75-90 years and above), not only to provide scientific information on a certain type of treatment (surgical or conservative) and clinical and fundamental recommendations, but also to acquire modern innovative technologies acceptable for preventive surgery and the ability to use them. For the advanced development of CSD surgery in the 21st century, it is important to identify the most susceptible individuals with high or very high risk for this pathology and their special prevention to ensure the process of early detection, effective and safe treatment (with proper pharmacovigilance, pharmacoepidemiological screening) and the prevention of not only CSD itself, but also formidable complications of cholecystectomy, cholecystostomy, choledochotomy, choledochomyotomy and transduodenal sphincteropapillotomy.